• Source: Imlunestrant

Imlunestrant is an experimental selective estrogen receptor degrader developed by Eli Lilly and Company for the treatment of some types of breast cancer.




References

Kata Kunci Pencarian:

• Imlunestrant
• Selective estrogen receptor degrader
• List of investigational sex-hormonal agents